Home » PROTEIN POLYMER TECHNOLOGIES ANNOUNCES INTENTION TO ACQUIRE SURGICA CORPORATION
PROTEIN POLYMER TECHNOLOGIES ANNOUNCES INTENTION TO ACQUIRE SURGICA CORPORATION
Protein Polymer Technologies, Inc. (OTC Bulletin Board: PPTI), a biotechnology device company that is a pioneer in protein design and synthesis, announced today that it has issued a letter of intent to acquire Surgica Corporation, a medical device company that develops, manufacturers and markets embolization products. Embolization is a minimally invasive procedure performed by interventional radiologists, used to treat uterine fibroids, liver cancer and neurovascular conditions.
MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqTxJqbWbmtK1Cda3nt)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May